MedTrace Logo

Gummy Candies With Maqui Berry

NCT07373795 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-01-28

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if Maqui berry gummy encapsulated (GMM) compared to non-encapsulated (GM) can improve glycemic response in overweight adults. It will also learn about the possible effect of serum antioxidant levels. The main questions it aims to answer are:

Does GMM or GM low the glycemic response in overweight/obese subjects after consuming a carbohydrate rich food?

Does GMM or GM increase antioxidant levels in overweight/obese subjects after consuming a carbohydrate rich food?

Researchers will compare (i) a carbohydrate rich food, (ii) GMM + a carbohydrate rich food, (iii) GM + a carbohydrate rich food to see if Maqui gummy work to control glycemic and antioxidant levels.

Participants will:

Take a carbohydrate rich food, and/or Maqui gummy three times, one week apart Have blood samples collected and answer food questionnaires in each visit

Conditions

  • Overweight (BMI > 25)
  • Obesity & Overweight
  • Insulin Resistance Syndrome
  • Type 2 Diabetes

Interventions

DIETARY_SUPPLEMENT

GM

white bread + GM: 150 g white bread plus 24 g GM (3 gummies)

DIETARY_SUPPLEMENT

Control

Baseline/control: 150 g white bread (75 g available carbohydrate)

DIETARY_SUPPLEMENT

GMM

white bread + GM: 150 g white bread plus 24 g GM (3 gummies)

Sponsors & Collaborators

  • Universidad de Valparaiso

    collaborator OTHER

  • Gonzalo Jorquera, PhD

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-02
Primary Completion
2026-01-13
Completion
2026-01-13

Countries

  • Chile

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07373795 on ClinicalTrials.gov